Abstract
Spontaneous reporting is a powerful and cost-effective tool for surveying drug safety after marketing, and has been able to identify more than 80% of unexpected adverse drug reactions. Making statistical calculations from spontaneous data, however, is frustrating, due to a variety of problems inherent to the system. This paper discusses guidelines for improving the quality of statistical calculations made on spontaneous reports.
Get full access to this article
View all access options for this article.
